NASDAQ: CLMT

Calumet (CLMT) Stock Analysis & Forecast

Nov 13 close

$34.30−2.15 (−5.9%)

Gekko Brief

AI summaryNov 9 close

Calumet reported record third-quarter 2026 results this week, with net income of $273.3 million and Adjusted EBITDA with Tax Attributes of $347.2 million, driven by strength in Specialty Products & Solutions and record earnings from Montana Renewables. Earnings per share of $2.910 topped a consensus estimate of $1.550, with one report citing $4.65 per share against a $1.21 consensus, and revenue reached $1.68 billion versus an estimated $1.26 billion. The company also continued deleveraging, retiring about $265 million of debt since July, though management noted the specialty supply windfall may not represent a new norm.

Despite the beat, the stock closed at $36.06, down 9% on the day and sitting between its 50-day average of $53.18 and 200-day average of $39.19, with one-month returns of -36.1% and one-year returns of 84.8%. The GekkoIndex reads 78.5, placing it in the Buying zone, and the price stands 15.4% below Gekko Fair Value of $42.62.

Over the next 20 trading days, the next earnings date falls on 26 February 2027, outside a typical holding window. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, though two trailblazer holders are noted. Seasonality from this point has averaged a 5.1% gain over 5 years, rising in 4 of them. Analyst consensus among 5 firms carries a target of $55.8, worth noting alongside the stock's typical 20-day move of 9.6%.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Calumet price vs fair value

$41.10$34.30Nov ’25May ’26Nov ’26
Close $34.30200-day averageGekko Fair Value $41.10

Calumet quick facts

Market cap
$3.02B
P/E ratio
—
Forward P/E
32.4
EPS, TTM
−$2.22
Revenue, TTM
$5.20B
Profit margin
-3.7%
Dividend yield
—
Beta
0.69
Volume
1.30M avg 1.66M
1-year return
+81.2%
Typical daily move
±8.7%
Typical 20-day move
±9.6%
50-day average
$51.86
200-day average
$39.46
Next earnings
Feb 26 before open
Shares outstanding
88.09M
52-week range
$17.85$59.87

Calumet swing-trade checklist

Calumet scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive1 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $34.30 sits between the 50-day ($51.86) and 200-day ($39.46) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    71.9, Buying

    Reading 71.9 is in the Buying zone.

    See the GekkoIndex
  • Fair valuesupportive

    16.5% below

    Price is 16.5% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 103 days

    Next report Feb 26, 2027, 103 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +1.4% on average

    From this point in the calendar, the next 20 trading days averaged +1.4% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Calumet stock chart and price history

Calumet closed at $34.30 on Nov 13, 2026, +81.2% over the past year, inside a 52-week range of $17.85 to $59.87.

Close50-day average200-day averageVolume
Calumet share price, past year, with 50-day and 200-day moving averages and volume$20$30$40$50$60DecJan 2026FebMarAprMayJunJulAugSepOctNov34.30

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−41.1%
3 months
−29.1%
6 months
+9.3%
1 year
+81.2%
The full CLMT chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CLMT in Gekko

Follow Calumet through every session

Put CLMT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track CLMT in GekkoFree for 7 days. No credit card required.

About Calumet

Calumet makes and sells specialty branded products along with renewable fuel, combining formulation work with manufacturing to serve customers who need tailored fuel and product solutions. Among its recognizable offerings are brands such as Royal Purple, Bel-Ray, and TruFuel.

The company organizes its work into distinct segments. One focuses on customer-driven formulation and specialty solutions, another centers on facilities in Montana, including a specialty asphalt plant in Great Falls and a renewables facility, and a third houses its branded performance products. A separate corporate segment covers general and administrative costs that are not tied to the other business lines.

Calumet was founded in 1919 and is headquartered in Indianapolis, Indiana. Its shares are listed on the NASDAQ under the ticker CLMT.

Listed
NASDAQ
Sector
Energy minerals
Industry
Oil refining/Marketing
Website
calumet.com

Calumet GekkoIndex: the smart money zone

Calumet’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 71.9, in the Buying zone, down 3.9 points over five sessions.

010071.9Buying

Down 3.9 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying (current zone)64+1.0%+5.7%+11.9%+18.6%
Accumulation120+0.7%+1.4%+3.7%+10.4%
Neutral444+1.4%+2.4%+3.9%+12.1%
Distribution71+0.2%−0.1%+4.4%+18.3%
Selling3Too few readings yet

Average CLMT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Buying readings averaged +2.9% over 20 days. Past behaviour doesn’t guarantee future results.

Buying zone: Smart money likely accumulating heavily. About the five zones →

See every daily GekkoIndex reading plotted over the CLMT price, zone by zone.Track CLMT in Gekko

Is Calumet stock overvalued? Gekko Fair Value

Calumet trades 16.5% below Gekko Fair Value of $41.10, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Calumet shares are worth, recalculated every trading day.

$41.10

Gekko Fair Value, Nov 14, 2026

16.5% Undervalued

At the end of Aug 2026 the price was 52.7% above the estimate.

Gekko Fair ValueShare price, month end
$41$34Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open CLMT in Gekko

Calumet insider and Congress trading

No open-market insider purchases were filed for Calumet, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for CLMT in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every CLMT insider filing, plotted on the chart in Gekko.Open CLMT in Gekko

Congress trades last 90 days

No trades in CLMT were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for CLMT, plotted on the chart in Gekko.Open CLMT in Gekko

Buybacks

Calumet has been buying back its own shares.

Bought back, year ended Dec 31, 2022
$4.40M
As a share of market cap
0.15%

From company filings.

Hedge funds and billionaires quarter ended Sep 30

0of the funds Gekko tracks hold CLMT.

0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko

Calumet earnings: next date and track record

Calumet reports on Feb 26, 2027, before the open (103 days away), and beat the EPS estimate in 5 of its last 8 reports.

5 of 8reports beat the EPS estimate
±9.3%average move across the report
2 of 8reports followed by a gain

Share-price move across each report

−10.1%Feb ’25+10.5%May ’25−11.0%Aug ’25−1.8%Nov ’25−9.3%Feb ’26−6.6%May ’26+8.6%Aug ’26−16.8%Nov ’26

Last earnings call, Nov 6, 2026 AI summary

What they said
Calumet generated $347M adjusted EBITDA in Q3, driven by $248M from Specialty Products and Solutions and a record $80M from Montana Renewables. Net leverage declined to ~3x from over 9x at the start of the prior year, with ~$550M in recourse debt retired. The company retired ~$265M of debt in four months, saving ~$26M in annual cash interest. Specialty volumes exceeded 20,000 barrels/day for the eighth consecutive quarter.
Guidance
Management expects continued deleveraging, with $175M of 2028 notes outstanding and 2029 notes becoming callable at par in January. The company anticipates sustained specialty market tightness due to physical plant damage affecting over 10% of global paraffinic base oil capacity.
ReportedEPSSurpriseRevenueSurpriseMove
Nov 6, 2026$2.91
est $1.63
+78.5%$1.68B
est $1.34B
+25.3%−16.8%
Aug 7, 2026−$0.05
est −$0.23
+78.3%$1.45B
est $1.12B
+29.3%+8.6%
May 8, 2026−$0.64
est −$0.57
−12.3%$1.03B
est $1.00B
+2.9%−6.6%
Feb 27, 2026−$0.43
est −$0.67
+35.8%$1.04B
est $1.06B
−1.8%−9.3%
Nov 7, 2025−$0.21
est −$0.30
+30.0%$1.08B
est $1.04B
+3.2%−1.8%
Aug 8, 2025−$1.70
est −$0.44
−286.4%$1.03B
est $1.15B
−11.1%−11.0%
May 9, 2025−$1.03
est −$0.41
−151.2%$993.9M
est $922.3M
+7.8%+10.5%
Feb 28, 2025−$0.17
est −$0.37
+53.2%$949.5M
est $866.2M
+9.6%−10.1%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Calumet stock forecast and analyst price targets

Analysts’ average 12-month price target for Calumet is $55.80, +62.7% from the last close, from 4 firms rating the stock in the last 90 days.

$55.80consensus 12-month target, +62.7% from the last close
Low $47High $75
Buy2
Hold2
Sell0

Each firm’s latest rating in the last 90 days: 4 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 9Bank of America SecuritiesBuy, maintained——
Nov 9H.C. WainwrightBuy, reiterated$75+118.7%
Oct 21Goldman SachsHold, maintained$57+66.2%
Sep 22H.C. WainwrightBuy, reiterated$75+118.7%
Sep 2H.C. WainwrightBuy, maintained$75+118.7%
+11.9%average 20-day move after past Buying readings
+1.4%average move over the next 20 trading days in the last 5 years
±8.7%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Calumet seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Calumet averaged +1.4% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−6.1%2021−21.1%2022+15.3%2023+4.3%2024+9.4%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+2.0%3 of 5
Next 10 trading days+5.0%4 of 5
Next 15 trading days+3.3%4 of 5
Next 20 trading days+1.4%3 of 5
Next 30 trading days+0.4%3 of 5

For scale, CLMT’s typical 20-trading-day move in either direction is about 9.6%.

Calumet market cap and key statistics

Calumet’s market cap is $3.02B and revenue of $5.20B over the last twelve months.

Valuation

Market cap
$3.02B
Forward P/E
32.4
EPS, TTM
−$2.22
Gekko Fair Value
$41.10

Trading

Volume
1.30M
Avg volume, 20 days
1.66M
52-week high
$59.87
52-week low
$17.85
Shares outstanding
88.09M

Financials

Revenue, TTM
$5.20B
Profit margin
-3.7%
Return on equity
-1172%
Quarterly earnings growth, YoY
−19.2%

Risk and income

Beta
0.69
Typical daily move
±8.7%
Typical 20-day move
±9.6%

Calumet peers

Calumet’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
MPCMarathon Petroleum−1.0%Accumulation4.9% below
VLOValero Energy+0.3%Accumulation0.8% above
PSXPhillips 66−0.4%Neutral7.9% above
DINOHF Sinclair−0.7%Accumulation5.1% above
PBFPBF Energy−0.7%Accumulation14.4% below
DKDelek US−0.8%Neutral12.4% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Oil refining/Marketing

Calumet stock FAQ

What is Calumet’s market cap?

Calumet’s market cap is $3.02B at the Nov 13, 2026 close of $34.30, with 88.09M shares outstanding.

What is the Calumet stock forecast?

The consensus analyst 12-month price target for Calumet is $55.80, +62.7% from the last close. Of the 4 firms that rated the stock in the last 90 days, 2 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Calumet stock overvalued or undervalued?

On Gekko’s estimate Calumet is undervalued: the Nov 13, 2026 close of $34.30 is 16.5% below Gekko Fair Value of $41.10. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Calumet report earnings next?

Calumet is expected to report on Feb 26, 2027, before the market opens (103 days away). Analysts expect earnings of $0.92 per share on revenue of $1.21B. Calumet beat the earnings estimate in 5 of its last 8 reports, moving 9.3% on average across the report.

What is Calumet’s 52-week high and low?

Calumet’s 52-week high is $59.87 and its 52-week low is $17.85; it closed at $34.30 on Nov 13, 2026, +81.2% over the past year.

Is Calumet stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Calumet the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.